Summary of opinion, Valdoxan, Thymanax - agomelatine - Paroxetine - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-07-21 05:05:41 Medicine Organofluorides Selective serotonin reuptake inhibitors Clinical research Pharmaceutical industry Agomelatine Melatonin European Medicines Agency Paroxetine Chemistry Organic chemistry Acetamides		Summary of opinion, Valdoxan, Thymanax - agomelatine Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 40,47 KB Share Document on Facebook

	Agomelatine cuts ocular pressure with glaucoma DocID: 11KGp - View Document
	The House of Cards…. Graylands Medical Group Thursday 13 December 2012 Geoff Smith WA Centre for Mental Health Policy Research DocID: UHp6 - View Document
	Psychostimulants in Psychiatry. Graylands Hospital Drug Bulletin DocID: UejG - View Document
	agomelatine, 25mg film-coated tablets (Valdoxan®) Servier Laboratories UK Ltd SMC No[removed]August 2010 DocID: TKwY - View Document
	PUBLIC SUMMARY DOCUMENT Product: AGOMELATINE, tablet, 25mg, Valdoxan® Sponsor: Servier Laboratories (Australia) Pty Ltd Date of PBAC Consideration: March[removed]Purpose of Application DocID: THeU - View Document